Cadrenal Therapeutics, Inc. Liquidation Value

CVKD Other

Cash & Equivalents

$4.01M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $4.01M
Total Obligations: -$1.59M
$2.42M
Per share: $1.03
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $4.01M
AR: $0
Total Obligations: -$1.59M
$2.42M
Per share: $1.03
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $4.01M
AR: $0
Inventory: $0
Total Obligations: -$1.59M
$2.42M
Per share: $1.03
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$2.42M$1.03
Liquid Liquidation Value$2.42M$1.03
Operating Liquidation Value$2.42M$1.03

Key Components (as of 2025-12-31)

Cash & Equivalents$4.01M
Accounts ReceivableN/A
InventoryN/A
Current Liabilities$1.59M
Long-term DebtN/A
Op. Lease Liability$2,232
Finance LeaseN/A
Shares Outstanding2.3M

Explore all 116 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$4.01MN/AN/A$650,663$1.59MN/AN/AN/A
2025-09-30$3.86MN/AN/A$614,127$1.35MN/AN/AN/A
2025-08-06$5.00MN/AN/AN/AN/AN/AN/AN/A
2025-06-30$5.57MN/AN/A$895,609$1.68MN/AN/AN/A
2025-03-31$7.34MN/AN/A$1.28M$1.84MN/AN/AN/A
2024-12-31$10.02MN/AN/A$1.50M$2.68MN/AN/AN/A
2024-09-30$4.36MN/AN/A$496,823$1.27MN/A$2,232N/A
2024-06-30$5.04MN/AN/A$759,518$1.46MN/A$8,796N/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-31 View
2025-09-30 10-Q 2025-11-10 View
2025-06-30 10-Q 2025-08-11 View
2025-03-31 10-Q 2025-05-08 View
2024-12-31 10-K 2025-03-13 View
2024-09-30 10-Q 2024-11-07 View
2024-06-30 10-Q 2024-08-07 View
2024-03-31 10-Q 2024-05-09 View

Community Notes

Loading notes...

Questions

Loading questions...